Autism with co-occurring epilepsy care pathway in Europe.

This study looked at how autistic children with epilepsy receive care in Italy, Spain, and the UK. Researchers found major problems: many autistic children aren't properly checked for epilepsy, those who have it don't always get the right treatment, and seizure medications are sometimes used incorrectly. There are no clear guidelines for helping autistic children who also have epilepsy. Families have to work very hard to get their children the right care.

This 2023 European study examined care pathways for autistic children with co-occurring epilepsy across Italy, Spain, and the United Kingdom. Researchers surveyed caregivers of autistic children (0-18 years) and consulted with the autistic community and professionals to identify barriers in epilepsy screening and treatment. The analysis revealed significant gaps including lack of systematic epilepsy screening for all autistic children, inadequate treatment of co-occurring epilepsy, and inappropriate antiepileptic drug use. A major challenge identified was the absence of evidence-based harmonized guidelines for autism with co-occurring epilepsy across these countries.

The study highlighted substantial heterogeneity in care pathways and significant efforts required by caregivers to access timely screening, diagnosis, and appropriate epilepsy management.

Results indicate urgent need for systematic epilepsy screening protocols for autistic children and development of evidence-based treatment guidelines. Healthcare systems should establish clear care pathways and improve coordination between autism and epilepsy specialists to reduce caregiver burden and improve outcomes.

The study methodology and sample size are not clearly reported in the abstract. The research appears to rely on surveys and stakeholder perspectives rather than clinical data. Findings may not be generalizable beyond the three European countries studied.

Autism and epilepsy often occur together. Epilepsy and other associated conditions have a substantial impact on the well-being of autistic people and their families, reduce quality of life, and increase premature mortality. Despite this, there is a lack of studies investigating the care pathway of autistic children with co-occurring epilepsy in Europe. We analyzed the care pathway for autistic children with associated epilepsy in Italy, Spain, and the United Kingdom from the perspective of caregivers (using a survey aimed at caregivers of autistic children 0-18 years old), the autistic community, and professionals, in order to identify major barriers preventing caregivers and autistic children from receiving timely screening and treatment of possible co-occurring epilepsy.

Across all three countries, an analysis of the current care pathway showed a lack of systematic screening of epilepsy in all autistic children, lack of treatment of co-occurring epilepsy, and inappropriate use of antiepileptic drugs. A major challenge is the lack of evidence-based harmonized guidelines for autism with co-occurring epilepsy in these countries. Our findings show both heterogeneity and major gaps in the care pathway for autism with associated epilepsy and the great efforts that caregivers must make for timely screening, diagnosis, and adequate management of epilepsy in autistic children. We call for policy harmonization in Europe in order to improve the experiences and quality of life of autistic people and their families.